5/20/2009

Boston Scientific has introduced in select global markets its TAXUS Element Paclitaxel-Eluting Coronary Stent System. The device uses platinum chromium alloy designed for coronary stent purposes and "represents the company's third-generation drug-eluting stent technology," Boston Scientific said.

Related Summaries